Xiaoxin Liu
Overview
Explore the profile of Xiaoxin Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ying B, Liu X, Yang C, Xu J, Chen Y
Lipids Health Dis
. 2024 Oct;
23(1):353.
PMID: 39478611
Background: Abnormalities in lipid metabolism are common among adult asthmatics. However, the precise directionality linking asthma to blood lipid levels remains controversial. Our study aimed to evaluate the association between...
12.
Liu X, Xia N, Yu Q, Jin M, Wang Z, Fan X, et al.
Metabolites
. 2024 Oct;
14(10).
PMID: 39452937
Background: Altered patterns of bile acids (BAs) are frequently present in liver fibrosis, and BAs function as signaling molecules to initiate inflammatory responses. Silybin meglumine (SLB-M) is widely used in...
13.
Zhou J, Liu X, Liang X, Wei S
Gen Hosp Psychiatry
. 2024 Aug;
90:150-156.
PMID: 39197229
Objective: The purpose of this study was to investigate the association between depressive symptoms and second primary cancer (SPC) in U.S. cancer survivors. Methods: Cancer survivors from the 2005-2018 National...
14.
Huang Z, Liao Y, Zheng Y, Ye S, Zhang Q, Yu X, et al.
Biol Trace Elem Res
. 2024 Jul;
PMID: 39028478
Chronic kidney disease (CKD) is a highly prevalent condition characterized by renal fibrosis as its ultimate manifestation. Zinc deficiency is closely associated with CKD, evidenced by its link to renal...
15.
Wang C, Liu X, Zhai J, Zhong C, Zeng H, Feng L, et al.
J Hazard Mater
. 2024 May;
472:134485.
PMID: 38701725
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a highly toxic persistent organic pollutant (POP) that can induce DNA damage within cells. Although oxidative stress is one of the primary mechanisms causing DNA damage, its...
16.
Guo Y, Xue H, Hu N, Liu Y, Sun H, Yu D, et al.
J Med Chem
. 2024 May;
67(10):7836-7858.
PMID: 38695063
The approval of venetoclax, a B-cell lymphoma-2 (Bcl-2) selective inhibitor, for the treatment of chronic lymphocytic leukemia demonstrated that the antiapoptotic protein Bcl-2 is a druggable target for B-cell malignancies....
17.
Liu X, Li Y, Li L, Li J, Yang J, Huang L, et al.
Cancer Nurs
. 2024 Apr;
PMID: 38598755
Background: Demoralization is a psychological syndrome that is highly prevalent in patients with cancer and detrimental to individuals' physical and mental health. To explore effective intervention, we first determined the...
18.
Liu X, Li X, Chen Y, Liu X, Liu Y, Wei H, et al.
Front Immunol
. 2024 Mar;
15:1331610.
PMID: 38449859
Objectives: The systemic immune-inflammation index (SII), a novel and systematic inflammatory biomarker that is associated with chronic kidney disease (CKD), has not received much attention. This study aimed to investigate...
19.
Liu J, Li S, Wang Q, Feng Y, Xing H, Yang X, et al.
Blood
. 2024 Jan;
143(18):1825-1836.
PMID: 38211332
Venetoclax, the first-generation inhibitor of the apoptosis regulator B-cell lymphoma 2 (BCL2), disrupts the interaction between BCL2 and proapoptotic proteins, promoting the apoptosis in malignant cells. Venetoclax is the mainstay...
20.
Liu T, Feng J, Liu X
Wideochir Inne Tech Maloinwazyjne
. 2023 Oct;
18(3):516-523.
PMID: 37868278
Introduction: Extensive subcutaneous emphysema may lead to a significantly prolonged hospital stay, cosmetic problems, and even death without timely treatment. However, the risk factors for it have been poorly studied....